AI Transparency Report
Disease Management Network Inc demonstrates consistent financial activity, with revenues generally exceeding expenses in recent years, contributing to asset growth. For example, in 2023, revenue was $4,455,056 against expenses of $4,144,020, leading to an increase in assets to $2,208,804. The organization's financial health appears stable, with a positive trend in net assets over the last few periods. However, the lack of reported officer compensation across all filings, despite significant revenue and expenses, raises questions about how leadership is compensated or if key personnel are volunteers, which could impact transparency regarding operational costs and executive oversight. The NTEE code T119 suggests a focus on disease-specific organizations, and without a detailed breakdown of program spending, it's difficult to fully assess spending efficiency beyond the overall revenue-to-expense ratio. The significant fluctuation in revenue, from $7,495,003 in 2019 to $2,100,003 in 2018 and then back up, indicates potential variability in funding sources or program scale.